C. Ng

Efficacy and safety of lapatinib as first-line therapy for ErbB2-amplified locally advanced or metastatic breast cancer.

H. Gómez, D. Doval, M. A. Chavez, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Efficacy and safety of maintenance erlotinib in Asian patients with advanced non-small-cell lung cancer: a subanalysis of the phase III, randomized SATURN study.

C. Ng, Keunchil Park, Yi-long Wu, 2012, Lung cancer.